- The new ROC will create 30 new jobs in 2026 and is expected to reach 40 positions by 2027
- The opening of this new operation represents the company’s fifth expansion in Costa Rica since 2017
San José, March 24, 2026. U.S.-based biopharmaceutical company MSD inaugurated its new Regulatory Operations Center (ROC) in Costa Rica on Tuesday -its second worldwide- which will support the acceleration of regulatory and specialized processes related to the development and registration of medicines and vaccines across its global markets.
The new ROC, located at the City Place development in Santa Ana, is expected to create 30 new jobs opportunities by the end of 2026 and scale to 40 positions in 2027. The operation will incorporate professionals from a range of disciplines, including medical sciences such as pharmacists, microbiologists, dentists, and nurses; chemical sciences such as biotechnologists and chemists; as well as engineering and technology profiles focused on artificial intelligence and hyper automation.
“The opening of the Regulatory Operations Center (ROC) in Costa Rica represents a strategic step for MSD, as it strengthens our ability to accelerate and optimize regulatory processes that enable us to deliver our products to patients more efficiently. Costa Rica’s selection as one of only two countries worldwide to host this center reflects the company’s confidence in local talent and its ability to support global-scale operations. This hub will allow us to work in a more integrated, efficient, and collaborative manner, with a direct impact on our mission to save and improve lives”, said Christian Swirgsde, Regulatory Operation Center Site Lead at MSD.
The opening of this new operation represents MSD’s fifth expansion in Costa Rica. Since 2017, the company has established teams in the country including Global Business Services (GBS), Global Pharmacovigilance Case Management (2018), Global Data Operations (2023), and Global Clinical Data Management (2024).
“With each expansion, we have strengthened our role as a strategic hub for the corporation. Today, we proudly celebrate the inauguration of the ‘Global Regulatory Affairs and Clinical Safety – Operations, Process and Systems’ operation, marking another important milestone in our evolution as a services hub. We are very proud to have started in 2017 with a commitment of 80 positions and to now exceed 550 roles, reflecting the trust placed in our team and the impact we generate within the organization and the business,” added Marco Rivera, Financial Processes and Control Director at MSD.
MSD’s new Regulatory Operations Center in Costa Rica is one of only two such centers globally, with the first located in Prague, Czech Republic.
“The inauguration of MSD’s Regulatory Operations Center marks the company’s fifth reinvestment in the country and reinforces confidence in Costa Rica as a competitive hub for high-value services. This investment will drive innovation and specialized talent, creating more quality job opportunities for our people,” said Indiana Trejos, Deputy Minister of Foreign Trade.
Laura López, CEO of the Trade and Investment Promotion Agency of Costa Rica (PROCOMER), noted that “MSD’s decision to continue expanding its operations in Costa Rica demonstrates the country’s strength as a destination where companies can grow and develop increasingly specialized operations and processes. The company’s choice of Costa Rica to establish its second Regulatory Operations Center worldwide reflects the quality of our talent and the country’s capabilities to take on more strategic functions, strengthening its role in key stages of the global pharmaceutical industry.”
Professionals interested in applying for the new job opportunities created by this ROC can do so through MSD LATAM’s LinkedIn profile and the MSD Careers portal MSD Career Jobs
About MSD
At MSD, known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada, we are united around a single purpose: we use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the world’s premier research-intensive biopharmaceutical company, and today we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.
We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable, and healthy future for people and communities worldwide. For more information, visit www.corporativo.msd.co.cr and connect with us on LinkedIn, Instagram and Twitter.
